← Leaderboards
David C Newitt
University Of Michigan At Ann Arbor
$1,856,415
Attributed
$5,604,290
Total exposure
2
Grants
0
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $1.2M · FY2015–19$2M$1.5M$1M$500K$0
'15
'16
'17
'18
'19
Funding mix
By agency
NIH$5,604,290 · 2
By mechanism
R01$5,604,290 · 2
Top collaborators
- Thomas L. Chenevert5 shared
- Nola M. Hylton5 shared
- Michael A Jacobs5 shared
- Ek Tsoon Tan4 shared
- Hui Wang4 shared
- Ajit Devaraj1 shared
- Luca Marinelli1 shared
Most similar at University Of Michigan At Ann Arbor
Same institution · by research overlap
- Brian D. Ross$27,286,369
- Theodore S Lawrence$30,022,406
- John O.l. Delancey$16,589,032
- Max S. Wicha$49,028,071
- Evan Todd Keller$23,141,123
Others in their field
Top investigators on “Investigation”
- Sonia M Thomas · Research Triangle Institute$700,865,642
- David Heimbrook · Leidos Biomedical Research, Inc.$681,473,477
- David Divins · Consortium For Ocean Leadership, Inc$609,772,544
- Tracy L Nolen · Research Triangle Institute$474,487,152
- Margaret Juliana McElrath · Fred Hutchinson Cancer Center$448,008,305
- Judith S. Currier · University Of California Los Angeles$395,422,692
Research focus
InvestigationTissuesClinical TrialsMagnetic Resonance ImagingResponseTechnologyPerformanceImageMeasurementProtocols DocumentationQuantitative ImagingResearch PersonnelBaseSiteDiffusionAmerican College Of Radiology Imaging NetworkEnvironmentGenerationsPublic Health RelevanceDiffusion Magnetic Resonance ImagingDiffusion WeightedIndustry PartnerProspective TestCancer Patient
Grant awards (10)
Elimination of Instrumental Bias for Quantitative Diffusion Imaging in Clinical Oncology Trials$587,059
R01 · FY2019 · CA
Real-time In Vivo MRI Biomarkers for Breast Cancer Pre-Operative Treatment Trials$468,077
R01 · FY2019 · CA
Elimination of Instrumental Bias for Quantitative Diffusion Imaging in Clinical Oncology Trials$610,045
R01 · FY2018 · CA
Real-time In Vivo MRI Biomarkers for Breast Cancer Pre-Operative Treatment Trials$483,603
R01 · FY2018 · CA
Elimination of Instrumental Bias for Quantitative Diffusion Imaging in Clinical Oncology Trials$615,807
R01 · FY2017 · CA
Real-time In Vivo MRI Biomarkers for Breast Cancer Pre-Operative Treatment Trials$487,259
R01 · FY2017 · CA
Elimination of Instrumental Bias for Quantitative Diffusion Imaging in Clinical Oncology Trials$634,801
R01 · FY2016 · CA
Real-time In Vivo MRI Biomarkers for Breast Cancer Pre-Operative Treatment Trials$497,317
R01 · FY2016 · CA
Elimination of Instrumental Bias for Quantitative Diffusion Imaging in Clinical Oncology Trials$704,723
R01 · FY2015 · CA
Real-time In Vivo MRI Biomarkers for Breast Cancer Pre-Operative Treatment Trials$515,599
R01 · FY2015 · CA